chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have a 101.5 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I have a 101.5 fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have a 101.5 fever). At the time of the report, PYREXIA (I have a 101.5 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) High.         No Relevant concomitant medications was reported.  Treatment information was not provided.
Erythema and induration at injection site. Started 03/31, day of the vax.
One day after administration, began to itch on sides of abdomen, noted red bumpy area. Later that day, same sign/symptom at injection site. Has progress to the following areas: bilateral arms, legs, back, neck, under breast unresolved at present 8 days post injection.
Ten minutes post-injection, pt. fell out of chair, exhibited loss of color with confusion; HR 64, RR 16.  Pt. has history of vagal with blood draw and injections.  Vitals taken every 10 minutes x 3.  Pt. placed in Trendelenburg position with nurse and doctor at bedside.  Pt. given water, food, and cold rag to neck.  Pt. color improved, alert, stable for dismissal.
Awakened 7FEB92 AM w/rt hand swollen, face, t102, stomach cramps, nausea, diarrhea; denied rash, throat tightness; Referred to hosp ER felt throat tightness once there; Impression by ER MD allergic rxn; No edema, redness of inject site;
itchy red palms and soles of feet; rash / hives all over body (especially back, chest, neck, and arms) treating with over-the-counter allergy medication on-going for two-weeks now
Pt had received Td on 10/15/03. Pt came to health unit on Friday morning, reporting that last night she felt shaky, cold, left arm swollen and having a bad headache. This AM she states her symptoms are better.
Graves Disease; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: BASEDOW'S DISEASE (medically significant), outcome "unknown", described as "Graves Disease".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Went into coma; Was knocked out; Had no energy; Very tired; Was in bed for 30hrs; This spontaneous case was reported by a consumer and describes the occurrence of COMA (Went into coma) and LOSS OF CONSCIOUSNESS (Was knocked out) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu-like illness in March 2021.   In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COMA (Went into coma) (seriousness criterion medically significant), LOSS OF CONSCIOUSNESS (Was knocked out) (seriousness criterion medically significant), ASTHENIA (Had no energy), BEDRIDDEN (Was in bed for 30hrs) and FATIGUE (Very tired). At the time of the report, COMA (Went into coma), LOSS OF CONSCIOUSNESS (Was knocked out), ASTHENIA (Had no energy) and FATIGUE (Very tired) outcome was unknown and BEDRIDDEN (Was in bed for 30hrs) had resolved.            Concomitant medications were not reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was Not Applicable.  Company Comment: This case concerns a 61-year-old male patient with previous medical history of Flu-like illness, who experienced the unexpected serious events of Coma and Loss of consciousness, non-serious unexpected events Asthenia and Bedridden and non-serious expected event of fatigue. Very limited information was provided regarding the events. The events were considered related to the product per the reporter's assessment. The rechallenge was unknown since there is limited information about the Moderna Covid-19 vaccine doses. The benefit-risk relationship of Covid-19 vaccine is not affected by this report.   This case was linked to MOD-2021-319992 (Patient Link).; Sender's Comments: This case concerns a 61-year-old male patient with previous medical history of Flu-like illness, who experienced the unexpected serious events of Coma and Loss of consciousness, non-serious unexpected events Asthenia and Bedridden and non-serious expected event of fatigue. Very limited information was provided regarding the events.The events were considered related to the product per the reporter's assessment. The rechallenge was unknown since there is limited information about the Moderna Covid-19 vaccine doses. The benefit-risk relationship of Covid-19 vaccine is not affected by this report.report.
The day after his second Pfizer vaccine, he developed hearing loss and had a CT scan of head that showed a large temporal lobe intracranial hemorrhage
Patient with known egg allergy given flu shot on 10/13/16 and observed in office for 30 minutes (has received vaccine in past). Patient mother called 10/14/16, left arm, swollen red, warm to touch. Patient seen in office by physician, 12 cm x 9 cm area of erythema, swelling, warmth noted.
I started feeling sick on December, I had a fever, really bad chills, extremely sore throat and coughing. I gave myself a COVID-19 test and it was positive. I broke out in hives a day after I had COVID-19. On 12/16/2022 I went to urgent care in an area that I don?t live in because I was visiting my family. They prescribed me a lotion called Triamcinolone Acetonide and I only used it once. I got home I made an appointment with my primary doctor because of the hives and they prescribed Claritin. Normally I would get the hives at night. I still have the hives occasionally.
Hospitalized 8/13/21 with positive Covid test and Colitis, diarrhea. Patient did not have respiratory symptoms and never required supplemental oxygen. Discharged home the next day with antibiotics.
pt devel an inj site rxn, characterized by induration & redness, following inj of vax;pt recovered;
On Feb 22nd patient received the vaccines listed below prior to travel overseas. She experienced some fever/chills and on the evening of the 25th developed numbness in her tongue. She awoke on the 26th with pain and numbness in her distal fingertips (bilaterally) and developed numbness on her cheek. She was seen by her primary MD due to numbness in her R arm. She was referred to ER and later admitted on the 27th. She recieved and MRI/MRA of brain. Her MRI showed small areas of focal ischemic changes (>20). MRA was normal. She was seen by Neurology and Rheumatology. She had an apparently extensive Rheum evaluation which was significant for several findings - most notable an elevated SSA (>1500) with some concern for Sjogren's Syndrome raised - evaluation in progress at time of report. Differential includes vaccine associated Acute Disseminated Encephalomyelitis (ADEM). Current treatment includes a tapering course of steroids and the patients symptoms appear to be resolving. Discharge summary states ADEM, dis-co-ordination. msv Medical records states asthenia. msv
A week after receiving the first dose of the COVID vaccine, I started to get a rash below the injection/shot site. It was very itchy, red, and warm to the touch. The next morning, it was about the size of a baseball, still itchy, red, and warm to the touch. The rash is still the same size today (2/16/2021), but not as red or itchy. I want to make sure it is safe to receive the next vaccine and if so, which arm I should receive it in.
Warmth, swelling, redness and tender to injection site area approximately 5 x 4 cm. Area marked and oral antibiotics started.
Shingles outbreak.  Received vaccine in left arm 1/10/08.  Several days later noted swollen LU in right axilla, followed by outbreak in T1 distributor (right side).
I had the appointment with my doctor for blood work 08/06/2021 and we went over my creatinine which went from 1.13 to 1.30. And the physical symptoms I had which I didn't connect at the time was puffiness, swelling in ankles, and when I was weighed, I gained a pound in a year, but my clothes weren't fitting right. That's when she prescribed 2.5mg of Zestril. She had me retest a week later and it went down to 1.24, still high but less than before. 08/19/2021 a week after the ace inhibitor. Creatinine has always been higher than normal for me but 1.3 was very unusual for me and bloating was awful. I don't eat a lot of salt to begin with, but I bloat a lot when I eat any salty food now. Not sure if this is connected. More blood testing in January.
Immediate burning sensation at injection site and swelling. Provided ice pack for area, swelling decreased within several minutes and patient left store after 15 minutes of observation
No Wheal on first Intradermal administration. Successful wheal on 2nd ID attempt.
Heart Attack - 3 weeks and 6 days post booster.   Have never had heart issues prior.
Arthritis back and fingers. Back surgery, chiropractor, physical therapy, Celebrex, Neurontin, hot tub. Follow up on 02/03/04: "Pt returns for a follow up evaluation. Since he was last seen by another MD in January of 2002 he reports that he has had an increase in his symptoms of pain and "tingling and numbness" about the left lateral thigh.  He describes his symptoms increasing threefold compared to his baseline.  This is worse with extension of his lumbar spine or hips, more so when standing than sitting. He denies any more distal numbness, weakness or tingling, or pain radiating down below the level of his knees. He has been otherwise well.  He now presents for elective follow up. On examination today he has some mild tenderness to palpation with radiating symptoms with deep palpation in the greater sciatic notch.  There is a mild area of tenderness though no discrete neuroma or nodular mass about his SIS. Neurologically he is intact throughout.  He has excellent motor strength throughout. He has 2+ symmetric knee and ankle jerks. His toes are downgoing. Sensation is intact to light tough throughout. The pt was seen and examined by another MD. At this time we feel that the pt indeed has a clinical examination as well as prior electrodiagnostic studies consistent with meralgia paresthetica. After extensive discussion regarding the risks and benefits of the procedure, including the possibility that his current symptoms may be due to degenerative changes of the lumbar spine, pt is in agreement with the plan for surgery. He is tentatively scheduled for 04/09/02. We will see him at the time of surgery.  Pt is here for follow up of a myelogram, post myelogram CT which demonstrates some stenosis of level 3-4 mildly at 4-5. He has what appears to be a listhesis at 4 and 5 but this will need to be further reviewed by the radiologist with MD.  His exam is unchanged. Strength, sensation, deep tendon reflexes reports and epidural injections helped his back pain for approximately two weeks. His has gotten better since his injection, although an MRI has shown a meniscal tear. Examination in regards to his left lower extremity demonstrates no pain on. He has pain on the anterior lateral aspect of his thigh, thought to be related to a neuralgia paresthetica.  He has resolution with regard to his knee pain.  His neuro exam is unchanged. The plan today is injection into the lateral femoral cutaneous nerve. This was done with a sterile technique. He tolerated it well. With no side-effects and signs of infection.  Follow up in three months time for reevaluation by MD.
10/6 L arm swelling and pain advised if worsen to see MD for evaluation. 10/7 small am't redness - no c/o.
severe sharp pain from the waist down.  It lasted about 24 hrs.  Two 325mg Tylenol every 3-4 hrs helped.
Chest pain on the following day (Aug 11), went to see a doctor in a clinic, and was directed to our hosipital. We diagnosed the patient with vaccine-induced myocarditis.
About half hour after visit patients mom called in and stated that they called ambulance due to patient having an anaphylactic reaction. Trouble  breathing and hives.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Shakiness-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: tingling, itching, rash development in his hands
mom reported child had swelling in the rt leg & it is itchy & reddened;swelling goes down to knee & is a little bit warm;otherwise child fine, walks fine;instructed to apply warm compress & call MD;
Patient's face turned red after receiving vaccination. She had trouble breathing and asked for a BENADRYL. She was given an epinephrine shot and immediately felt better.
Patient was given the wrong Covid 19 Booster.  Patient had previously received the Pfizer 2 shot series.  And was given a Moderna Booster accidently.
Information has been received concerning an 85 year old female with sulfonamide allergy and procaine allergy and a history of lung cancer, hypothyroidism and osteoporosis who on 13-OCT-2007 was vaccinated with a single dose of ZOSTAVAX. Concomitant therapy included ACTONEL, SYNTHROID, ATARAX and BENICAR. On 14-OCT-2007 the patient developed herpes zoster on the left flank and back. The patient was examined in the office on 15-OCT-2007 and was prescribed acyclovir and TYLENOL#3. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Please describe the adverse event(s) (up to 1000 characters): After the first Vaccine, I developed a constant sense of smelling smoke. This smell was so strong that at times, I could even taste it. This continued the entire 3 weeks until the 2nd vaccine. After the second vaccine, the smoke smell noticeably decreased, disappearing the 2nd day after the 2nd vaccine. But a new smell developed in its place; a smell that is more difficult to label. I am describing it as soured olive oil. This new smell is much more problematic, because now, everything I eat tastes like soured oil. An experiment: Since those who sell perfume clear their sense of smell with a sachet of coffee beans, I took a whiff of some ground coffee but it only smelled like a stronger version of the sour oil. I can taste nothing however spicy, nor anything that is savory. It all tastes like the dull, almost rancid taste of oil. Since there is no third vaccine to change my smell/taste, how long should I expect this condition last?
This patient had the moderna vaccine administered during a mass vaccination event. The patient is under age, sustained no physical adverse events, and has been alerted that he will not be recieving his second dose until he reaches age 18.
Started with neck pain/stiffness that progressed to transit joint pain, especially hips, knees, hand plus some myalgia & abdominal discomfort about 4-5 hours after injections; 2 ADVIL taken before bed that helped decrease symptoms. The next day, joint pain, especially neck, knees, shoulders and abdominal discomfort continued and then worsened significantly by 12:00 PM, at which time significant fatigue and myalgia was noted at which time I was unable to complete ADLs. About 2:00, chills set in and by 5:00 I was found to have a fever of 100.3 F. At this time, 4 ADVIL were taken and the symptoms decreased. Today is day 3 and I still have neck & hip pain (worst) and mild generalized joint discomfort. SHINGRIX injection site remains somewhat painful at use of left arm and is tender to touch. MMR site (R arm) is non-tender.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 09-NOV-2015, the patient was vaccinated with an improperly stored PNEUMOVAX 23, lot # L002310, expiration date 08-JUL-2016, at a dose of 0.5 ml, (route and anatomical location of administration were unspecified). The vaccine underwent a total temperature excursion, of 208 hours. The lowest recorded temperature was 34 Fahrenheit degrees (1.111111111 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Myalgias with fever 10/17/16. Diabetic appt 10/18/16-admins PNEUMOVAX (L) deltoid and Tdap (R) deltoid. Developed 102 fever 10/18/16.
pt recvd vax & exp lump on rt arm lower deltoid rt upper external area-raised indurated area, tender to touch w/white scaly flaky surface about 1/2in diameter w/hyperpigmented border
No other AE; Medical assistant called to report a temperature excursion / ROTATEQ was administered to a patient on 17/SEP/2021; This spontaneous report was received from a medical assistant referring to a 9-week-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On 17-SEP-2021, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, one time dose orally administered as prophylaxis (lot number 1741377 which has been verified to be valid, expiration date reported and validated as 07-MAR-2022). The administered dose of the vaccine was stored at a temperature of 35.02 degrees Fahrenheit (F), during a time frame of 19 hours (product storage error). There was no previous temperature excursion. No other adverse events were reported in the patient.
No adverse event; The caller said a dose was administered to a patient after a temperature excursion occurred.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 25-JAN-2022, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, 1 dose, lot #U008315, expiration date: 15-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided) after a temperature excursion occurred. The vaccine underwent a temperature excursion of 0.5 degree Celsius (C) for a period of 168 hours (product storage error). The vaccine did not undergo previous temperature excursion. The patient did not experience any adverse event.
3 episodes of fever-1st time evening of shot, highest temp 102, stares; fever today 99.7 seen by MD 24AUG92;
Received the first dose of vaccine, no problems for 12 hours, then I started to have non-stop shivering and fevers for almost 18 hours then felt better.
This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old male patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE) (Lot number; EN6203) via an unspecified route of administration in left arm on 12Mar2021 at 10.00AM as a single dose for COVID-19 immunization. The patient received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE) (Lot number; EL3247) via an unspecified route of administration in left arm on 19FEB2021 10:00 AM as a single dose for COVID-19 immunization. Medical history and concomitant medication was not reported. Patient was allergic to Iodine. Prior to vaccination, patient was not diagnosed with COVID-19, since the vaccination, patient was not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 12Mar2021 at 23:00 hours. the patient experienced body temperature (101 degrees), headache, diarrhea, nausea, chills, fatigue and body aches. The clinical outcome of the reported events was recovered at the time of this report.    No follow-up attempts are possible. No further information is expected.
Fever 105;pale; to ER cool baths ASA, APAP pt seen by MD dx w/beginning ear infection;
Neuropathy in legs and feet. I have been treated for this matter and is still dealing with the nerve damage and pain daily. I have been tested for numerous issues in on behind this neuropathy. All of my test came back good no diabetes or anything else that would have caused this issue. I e been dealing with this since the last dose of vaccination also taking numerous medications to at least ease some of the pain and nerve damage. I've been prescribed numerous of medications and at the moment the only thing that is easing this pain is Lyrica 150 mg tid and tramadol 50 mg qid prn
This spontaneous report has been received from a heath professional concerning a patient of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. On 15-APR-2015, the patient was vaccinated with an improperly stored dose of M-M-R II, (lot #, strength, route of administration and dose were not provided). No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Vaccine administered was for age group 5-11 patient and patient should have received dosage for 12-17 y.o.
(Rash on front of legs) Itching/Right Elbow itching/Left Elbow Itching; Rash on the front of legs; Chills Really Bad for 2 days; "No Good"; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS ((Rash on front of legs) Itching/Right Elbow itching/Left Elbow Itching), RASH (Rash on the front of legs), CHILLS (Chills Really Bad for 2 days) and MALAISE ("No Good") in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C1A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced CHILLS (Chills Really Bad for 2 days) and MALAISE ("No Good"). On 13-Jun-2021, the patient experienced PRURITUS ((Rash on front of legs) Itching/Right Elbow itching/Left Elbow Itching) and RASH (Rash on the front of legs). The patient was treated with IBUPROFEN ongoing from 11-Jun-2021 at a dose of 1 dosage form and LORATADINE (CLARITIN [LORATADINE]) ongoing from 14-Jun-2021 at a dose of 10 mg. On 13-Jun-2021, CHILLS (Chills Really Bad for 2 days) had resolved. On 15-Jun-2021, PRURITUS ((Rash on front of legs) Itching/Right Elbow itching/Left Elbow Itching) had resolved. At the time of the report, RASH (Rash on the front of legs) had not resolved and MALAISE ("No Good") outcome was unknown.            No concomitant medication were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-221984 (Patient Link).
Large swelling of lymph nodes under left arm, at elbow, collar bone - pain and soreness neck and left arm & fever.
Pain in right arm. Acute at time. Disrupted over time. Activated again with subsequent vaccines, flu and second dose. Ongoing right arm pain since summer. Upper part of arm on right only. Not interfering with fx, but noticeable each day.